Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies [PDF]
Background Analysis of muscle biopsies allowed to characterize the pathophysiological changes of Duchenne and Becker muscular dystrophies (D/BMD) leading to the clinical phenotype.
Pietro Spitali +16 more
doaj +8 more sources
Measuring Disease Severity in Duchenne and Becker Muscular Dystrophy
Medical investigations use a wide variety of outcome indicators that are often not comparable. It can be challenging to integrate results across multiple studies that do not share a common metric.
Melinda F. Davis +3 more
doaj +4 more sources
Development of a Clinicopathological Prognostic Model and Risk Classification to Predict Disease-Free Survival in Patients with Gastric Adenocarcinoma Following Neoadjuvant Chemotherapy and Curative Gastrectomy [PDF]
Background: Prognostic assessment after neoadjuvant chemotherapy and curative gastrectomy remains challenging in patients with gastric adenocarcinoma because postoperative outcomes are influenced by both pretreatment disease burden and pathological ...
Erdoğan Şeyran, Emre Hafızoğlu
doaj +2 more sources
Genotype–Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease Registry [PDF]
Duchenne muscular dystrophy (DMD) is a fatal neuromuscular disorder generally caused by out-of-frame mutations in the DMD gene. In contrast, in-frame mutations usually give rise to the milder Becker muscular dystrophy (BMD). However, this reading frame rule does not always hold true. Therefore, an understanding of the relationships between genotype and
Toshifumi Yokota +2 more
exaly +3 more sources
Errata: Measuring Disease Severity in Duchenne and Becker Muscular Dystrophy
Reports an error in Davis et al. (2010). The functional motor scale used in Davis et al. (2010) was the EK (Egen Klassifikation) Scale, rather than the Amyotrophic Lateral Sclerosis Functional Rating Scale (Steffensen et al., 2002; Cedarbaum Stambler ...
Melinda F. Davis +3 more
doaj +4 more sources
IntroductionElevated transaminases and/or creatine phosphokinase can indicate underlying muscle disease. Therefore, this study aims to determine the frequency of Duchenne muscular dystrophy/Becker muscular dystrophy (DMD/BMD) in male children and Pompe ...
Aydan Kansu +93 more
doaj +3 more sources
Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
Mutations of the dystrophin DMD gene, essentially deletions of one or several exons, are the cause of two devastating and to date incurable diseases, Duchenne (DMD) and Becker (BMD) muscular dystrophies.
Elisabeth Le Rumeur
doaj +4 more sources
IntroductionDuchenne/Becker muscular dystrophies (DMD/BMD) are inherited muscle diseases, collectively referred to as dystrophinopathy, which are characterized by progressive degeneration or loss. Although serum creatine kinase (CK) is a classical biomarker of DMD and BMD, it alone cannot clearly differentiate between severe DMD and milder BMD.
Masafumi Matsuo +2 more
exaly +4 more sources
Complementary targeted constructs factor XI/XIa inhibition [PDF]
Richard C. Becker
doaj +2 more sources
Foundation: Duchenne and Becker muscular dystrophies are progressive neuromuscular diseases with a pattern of recessive inherited link to chromosome X and caused by mutations in the gene which codifies for dystrophin.
Ivonne Martín Hernández +4 more
doaj +1 more source

